Selected research
Market Structure
Global Female Contraceptives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Female Contraceptives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Female Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Female Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Female Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Female Contraceptives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Female Contraceptives include Teva, Johnson & Johnson, Merck, Mylan, Pfizer, Bayer, Mayer Laboratories, Lupin Pharmaceuticals and Fuji Latex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Female Contraceptives market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Female Contraceptives and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Female Contraceptives revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Female Contraceptives market size, projected growth trends, production technologies, key applications, and end-use industries.
Female Contraceptives Segment by Company
Teva
Johnson & Johnson
Merck
Mylan
Pfizer
Bayer
Mayer Laboratories
Lupin Pharmaceuticals
Fuji Latex
Female Health Company
Female Contraceptives Segment by Type
Female Contraceptive Devices
Female Contraceptive Drugs
Female Contraceptives Segment by Application
Online Stores
Retail Outlets
Female Contraceptives Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Female Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female Contraceptives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Female Contraceptives in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Female Contraceptives industry.
Chapter 3: Detailed analysis of Female Contraceptives companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Female Contraceptivesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Female Contraceptive Devices
- Female Contraceptive Drugs
Applications
- Online Stores
- Retail Outlets
Companies covered
- Teva
- Johnson & Johnson
- Merck
- Mylan
- Pfizer
- Bayer
- Mayer Laboratories
- Lupin Pharmaceuticals
- Fuji Latex
- Female Health Company
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Female Contraceptives Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Female Contraceptive Devices
- 1.2.3 Female Contraceptive Drugs
- 1.3 Market Analysis by Application
- 1.3.1 Global Female Contraceptives Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Online Stores
- 1.3.3 Retail Outlets
- 1.4 Global Market Growth Prospects
- 1.5 Global Female Contraceptives Growth Trends by Region
- 1.5.1 Global Female Contraceptives Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Female Contraceptives Market Size by Region (2021-2026)
- 1.5.3 Female Contraceptives Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Female Contraceptives Market Dynamics
- 2.1 Female Contraceptives Industry Trends
- 2.2 Female Contraceptives Industry Drivers
- 2.3 Female Contraceptives Industry Opportunities and Challenges
- 2.4 Female Contraceptives Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Female Contraceptives Revenue by Company (2021-2026)
- 3.2 Global Female Contraceptives Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Female Contraceptives Key Company Head office and Area Served
- 3.4 Global Female Contraceptives Company, Product Type & Application
- 3.5 Global Female Contraceptives Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Female Contraceptives Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Female Contraceptives Players Market Share by Revenue in 2025
- 3.6.3 2025 Female Contraceptives Tier 1, Tier 2, and Tier 3
4 Female Contraceptives Market by Type
- 4.1 Global Female Contraceptives Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Female Contraceptives Market Size by Type (2021-2032)
- 4.3 Global Female Contraceptives Market Size Share by Type (2021-2032)
5 Female Contraceptives Market by Application
- 5.1 Global Female Contraceptives Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Female Contraceptives Market Size by Application (2021-2032)
- 5.3 Global Female Contraceptives Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Female Contraceptives Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Teva Female Contraceptives Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Female Contraceptives Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Johnson & Johnson Female Contraceptives Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Merck
- 6.3.1 Merck Company Information
- 6.3.2 Merck Business Overview
- 6.3.3 Merck Female Contraceptives Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Merck Female Contraceptives Product Portfolio
- 6.3.5 Merck Recent Developments
- 6.4 Mylan
- 6.4.1 Mylan Company Information
- 6.4.2 Mylan Business Overview
- 6.4.3 Mylan Female Contraceptives Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Mylan Female Contraceptives Product Portfolio
- 6.4.5 Mylan Recent Developments
- 6.5 Pfizer
- 6.5.1 Pfizer Company Information
- 6.5.2 Pfizer Business Overview
- 6.5.3 Pfizer Female Contraceptives Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Pfizer Female Contraceptives Product Portfolio
- 6.5.5 Pfizer Recent Developments
- 6.6 Bayer
- 6.6.1 Bayer Company Information
- 6.6.2 Bayer Business Overview
- 6.6.3 Bayer Female Contraceptives Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Bayer Female Contraceptives Product Portfolio
- 6.6.5 Bayer Recent Developments
- 6.7 Mayer Laboratories
- 6.7.1 Mayer Laboratories Company Information
- 6.7.2 Mayer Laboratories Business Overview
- 6.7.3 Mayer Laboratories Female Contraceptives Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Mayer Laboratories Female Contraceptives Product Portfolio
- 6.7.5 Mayer Laboratories Recent Developments
- 6.8 Lupin Pharmaceuticals
- 6.8.1 Lupin Pharmaceuticals Company Information
- 6.8.2 Lupin Pharmaceuticals Business Overview
- 6.8.3 Lupin Pharmaceuticals Female Contraceptives Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Lupin Pharmaceuticals Female Contraceptives Product Portfolio
- 6.8.5 Lupin Pharmaceuticals Recent Developments
- 6.9 Fuji Latex
- 6.9.1 Fuji Latex Company Information
- 6.9.2 Fuji Latex Business Overview
- 6.9.3 Fuji Latex Female Contraceptives Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Fuji Latex Female Contraceptives Product Portfolio
- 6.9.5 Fuji Latex Recent Developments
- 6.10 Female Health Company
- 6.10.1 Female Health Company Company Information
- 6.10.2 Female Health Company Business Overview
- 6.10.3 Female Health Company Female Contraceptives Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Female Health Company Female Contraceptives Product Portfolio
- 6.10.5 Female Health Company Recent Developments
7 North America
- 7.1 North America Female Contraceptives Market Size (2021-2032)
- 7.2 North America Female Contraceptives Market Size by Type
- 7.2.1 North America Female Contraceptives Market Size by Type (2021-2026)
- 7.2.2 North America Female Contraceptives Market Size by Type (2027-2032)
- 7.2.3 North America Female Contraceptives Market Share by Type (2021-2032)
- 7.3 North America Female Contraceptives Market Size by Application
- 7.3.1 North America Female Contraceptives Market Size by Application (2021-2026)
- 7.3.2 North America Female Contraceptives Market Size by Application (2027-2032)
- 7.3.3 North America Female Contraceptives Market Share by Application (2021-2032)
- 7.4 North America Female Contraceptives Market Size by Country
- 7.4.1 North America Female Contraceptives Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Female Contraceptives Market Size by Country (2021-2026)
- 7.4.3 North America Female Contraceptives Market Size by Country (2027-2032)
- 7.4.4 North America Female Contraceptives Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Female Contraceptives Market Size (2021-2032)
- 8.2 Europe Female Contraceptives Market Size by Type
- 8.2.1 Europe Female Contraceptives Market Size by Type (2021-2026)
- 8.2.2 Europe Female Contraceptives Market Size by Type (2027-2032)
- 8.2.3 Europe Female Contraceptives Market Share by Type (2021-2032)
- 8.3 Europe Female Contraceptives Market Size by Application
- 8.3.1 Europe Female Contraceptives Market Size by Application (2021-2026)
- 8.3.2 Europe Female Contraceptives Market Size by Application (2027-2032)
- 8.3.3 Europe Female Contraceptives Market Share by Application (2021-2032)
- 8.4 Europe Female Contraceptives Market Size by Country
- 8.4.1 Europe Female Contraceptives Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Female Contraceptives Market Size by Country (2021-2026)
- 8.4.3 Europe Female Contraceptives Market Size by Country (2027-2032)
- 8.4.4 Europe Female Contraceptives Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Female Contraceptives Market Size (2021-2032)
- 9.2 China Female Contraceptives Market Size by Type
- 9.2.1 China Female Contraceptives Market Size by Type (2021-2026)
- 9.2.2 China Female Contraceptives Market Size by Type (2027-2032)
- 9.2.3 China Female Contraceptives Market Share by Type (2021-2032)
- 9.3 China Female Contraceptives Market Size by Application
- 9.3.1 China Female Contraceptives Market Size by Application (2021-2026)
- 9.3.2 China Female Contraceptives Market Size by Application (2027-2032)
- 9.3.3 China Female Contraceptives Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Female Contraceptives Market Size (2021-2032)
- 10.2 Asia Female Contraceptives Market Size by Type
- 10.2.1 Asia Female Contraceptives Market Size by Type (2021-2026)
- 10.2.2 Asia Female Contraceptives Market Size by Type (2027-2032)
- 10.2.3 Asia Female Contraceptives Market Share by Type (2021-2032)
- 10.3 Asia Female Contraceptives Market Size by Application
- 10.3.1 Asia Female Contraceptives Market Size by Application (2021-2026)
- 10.3.2 Asia Female Contraceptives Market Size by Application (2027-2032)
- 10.3.3 Asia Female Contraceptives Market Share by Application (2021-2032)
- 10.4 Asia Female Contraceptives Market Size by Country
- 10.4.1 Asia Female Contraceptives Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Female Contraceptives Market Size by Country (2021-2026)
- 10.4.3 Asia Female Contraceptives Market Size by Country (2027-2032)
- 10.4.4 Asia Female Contraceptives Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Female Contraceptives Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Female Contraceptives Market Size by Type
- 11.2.1 South America, Middle East & Africa Female Contraceptives Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Female Contraceptives Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Female Contraceptives Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Female Contraceptives Market Size by Application
- 11.3.1 South America, Middle East & Africa Female Contraceptives Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Female Contraceptives Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Female Contraceptives Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Female Contraceptives Market Size by Country
- 11.4.1 South America, Middle East & Africa Female Contraceptives Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Female Contraceptives Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Female Contraceptives Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Female Contraceptives Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst